Caitong International Asset Management’s TuHURA Biosciences HURA Stock Holding History

Caitong International Asset Management’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70	Buy	+30	New	+$70	﹤0.01%	2275

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Caitong International Asset Management's HURA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 30 shares worth $70. The stake represents ﹤0.01% of the portfolio and ranks #2275 among its holdings.

90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Caitong International Asset Management held 30 shares of TuHURA Biosciences worth $70 as of Q2 2026.
TuHURA Biosciences was a new Caitong International Asset Management position in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2275 holding.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.